Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGTY
801
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $20.1M | 0.03% |
1,958,200
+45,900
| +2% | +$475K |
|
802
Best Buy
BBY
$17.5B
| $20.1M | 0.03% |
409,200
-3,184,600
| -89% | -$142M |
|
|
MFA
803
MFA Financial
MFA
$925M
| $20.1M | 0.03% |
621,159
-19,441
| -3% | -$620K |
|
804
AB InBev
BUD
$156B
| $20.1M | 0.03% |
182,900
-154,100
| -46% | -$16.6M |
|
805
Strategy Inc
MSTR
$37.3B
| $20M | 0.03% |
1,063,000
+552,000
| +108% | +$10.7M |
|
806
Core Laboratories
CLB
$571M
| $19.9M | 0.03% |
+172,100
| New | +$20M |
|
|
IPCC
807
DELISTED
Infinity Property & Casualty C
IPCC
| $19.9M | 0.03% |
208,100
+9,400
| +5% | +$853K |
|
808
Genpact
G
$5.7B
| $19.9M | 0.03% |
+802,500
| New | +$19.6M |
|
809
AMC Global Media
AMCX
$485M
| $19.7M | 0.03% |
336,200
-325,700
| -49% | -$18.7M |
|
|
ALX
810
Alexander's
ALX
$1.39B
| $19.7M | 0.03% |
45,600
+5,500
| +14% | +$2.35M |
|
|
GGP
811
DELISTED
GGP Inc.
GGP
| $19.7M | 0.03% |
849,500
+404,500
| +91% | +$9.9M |
|
812
Teck Resources
TECK
$32.4B
| $19.7M | 0.03% |
898,876
-347,800
| -28% | -$7.77M |
|
|
BRKL
813
DELISTED
Brookline Bancorp
BRKL
| $19.7M | 0.03% |
1,256,800
+138,200
| +12% | +$2.18M |
|
814
Enviri
NVRI
$583M
| $19.7M | 0.03% |
1,542,300
+219,300
| +17% | +$2.93M |
|
815
Fortive
FTV
$18.6B
| $19.6M | 0.03% |
+516,642
| New | +$18.5M |
|
816
IPG Photonics
IPGP
$3.71B
| $19.6M | 0.03% |
162,539
+34,139
| +27% | +$3.86M |
|
|
ALR
817
DELISTED
Alere Inc
ALR
| $19.6M | 0.03% |
493,324
+417,324
| +549% | +$16.3M |
|
|
ANH
818
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $19.6M | 0.03% |
3,528,120
+219,090
| +7% | +$1.17M |
|
|
FRC
819
DELISTED
First Republic Bank
FRC
| $19.6M | 0.03% |
+208,600
| New | +$19.6M |
|
|
CADE
820
DELISTED
Cadence Bank
CADE
| $19.5M | 0.03% |
646,100
-391,991
| -38% | -$12M |
|
|
MNR
821
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $19.5M | 0.03% |
1,367,600
+171,100
| +14% | +$2.49M |
|
822
Teradyne
TER
$63B
| $19.5M | 0.03% |
627,101
-509,099
| -45% | -$14.6M |
|
823
Applied Industrial Technologies
AIT
$13B
| $19.4M | 0.03% |
313,700
-21,150
| -6% | -$1.31M |
|
824
New Oriental
EDU
$8.49B
| $19.3M | 0.03% |
320,400
-326,000
| -50% | -$16.5M |
|
|
BSTC
825
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $19.3M | 0.03% |
352,627
+19,881
| +6% | +$1.05M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.